Barco Secures FDA Product Variance for Laser Projection

Bookmark and Share

Tue, 04/15/2014 - 14:09 -- Nick Dager

The U.S. Food and Drug Administration has granted a product variance for Barco’s 6 primary laser 3D (6P) laser-illuminated projector. The FDA has also granted approval for a predefined laser show variance, allowing U.S.-based exhibitors to safely install the 4K Barco laser projector without excessive legal constraints and extra costs. In this way, exhibitors who install the Barco laser projector do not need to prove compliancy with the same stringent regulations as laser light shows.

“By receiving a US FDA product variance for our fully integrated laser-illuminated projector – the most compact and efficient 6 primary laser 3D (6P) laser-illuminated projector on the planet – we provide U.S. exhibitors hassle-free and worry-free installation of our projector, delivering true peace of mind,” said Goran Stojmenovik, product manager Laser Projection at Barco. “This is a great step in the right direction for laser-illuminated projection technology regulations worldwide.” Barco was one of the founding members of the Laser Illuminated Projector Association in 2011, striving for an internationally harmonized regulation and standard for laser-illuminated projection.

“LIPA is striving to have laser-illuminated projectors classified so that they comply with rules similar to those for lamp-based projectors. Today’s outdated regulations would burden cinema exhibitors who install laser-illuminated projectors with needlessly stringent and costly requirements,” said Bill Beck, LIPA co-founder and former chairman. “We have already come a long way and, as an international standard for laser-illuminated projection regulation is now within reach, we believe the future looks very promising.”

Follow the Barco laser blog